Occurrence of select perfluoroalkyl substances at US Air Force aqueous film-forming foam release sites other than fire training areas: Field validation of critical fate and … RH Anderson, GC Long, RC Porter, JK Anderson Perfluoroalkyl Substances in the Environment, 353-372, 2018 | 392 | 2018 |
Environmental investigation and remediation: 1, 4-dioxane and other solvent stabilizers TKG Mohr, W DiGuiseppi, J Hatton, J Anderson CRC Press, 2020 | 313 | 2020 |
Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment RS Thomas, HJ Clewell III, BC Allen, SC Wesselkamper, NCY Wang, ... Toxicological sciences 120 (1), 194-205, 2011 | 139 | 2011 |
Co-occurrence of 1,4-Dioxane with Trichloroethylene in Chlorinated Solvent Groundwater Plumes at US Air Force Installations: Fact or Fiction RH Anderson | 137 | 2012 |
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells A Sharma, CES Comstock, ES Knudsen, KH Cao, JK Hess-Wilson, ... Cancer research 67 (13), 6192-6203, 2007 | 98 | 2007 |
Environmental sources, chemistry, fate, and transport of per‐and polyfluoroalkyl substances: State of the science, key knowledge gaps, and recommendations presented at the … JL Guelfo, S Korzeniowski, MA Mills, J Anderson, RH Anderson, ... Environmental Toxicology and Chemistry 40 (12), 3234-3260, 2021 | 94 | 2021 |
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer YB Wetherill, JK Hess-Wilson, CES Comstock, SA Shah, CR Buncher, ... Molecular cancer therapeutics 5 (12), 3181-3190, 2006 | 90 | 2006 |
Differences between human and rat intestinal and hepatic bisphenol A glucuronidation and the influence of alamethicin on in vitro kinetic measurements CS Mazur, JF Kenneke, JK Hess-Wilson, JC Lipscomb Drug Metabolism and Disposition 38 (12), 2232-2238, 2010 | 80 | 2010 |
Application of a framework for grouping and mixtures toxicity assessment of PFAS: A closer examination of dose-additivity approaches PE Goodrum, JK Anderson, AL Luz, GK Ansell Toxicological Sciences 179 (2), 262-278, 2021 | 79 | 2021 |
Endocrine disrupting compounds and prostate cancer JK Hess-Wilson, KE Knudsen Cancer letters 241 (1), 1-12, 2006 | 72 | 2006 |
Perfluorohexanoic acid toxicity, part I: Development of a chronic human health toxicity value for use in risk assessment AL Luz, JK Anderson, P Goodrum, J Durda Regulatory Toxicology and Pharmacology 103, 41-55, 2019 | 61 | 2019 |
Unique bisphenol A transcriptome in prostate cancer: Novel effects on ERβ expression that correspond to androgen receptor mutation status JK Hess-Wilson, SL Webb, HK Daly, YK Leung, J Boldison, ... Environmental health perspectives 115 (11), 1646-1653, 2007 | 49 | 2007 |
Perfluorohexanoic acid toxicity, part II: Application of human health toxicity value for risk characterization JK Anderson, AL Luz, P Goodrum, J Durda Regulatory Toxicology and Pharmacology 103, 10-20, 2019 | 47 | 2019 |
Application of computational toxicological approaches in human health risk assessment. I. A tiered surrogate approach NCY Wang, QJ Zhao, SC Wesselkamper, JC Lambert, D Petersen, ... Regulatory Toxicology and Pharmacology 63 (1), 10-19, 2012 | 45 | 2012 |
Xenoestrogen action in breast cancer: impact on ER-dependent transcription and mitogenesis JK Hess-Wilson, J Boldison, KE Weaver, KE Knudsen Breast cancer research and treatment 96, 279-292, 2006 | 34 | 2006 |
Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts JK Anderson, RW Brecher, IT Cousins, J DeWitt, H Fiedler, K Kannan, ... Regulatory toxicology and pharmacology 134, 105226, 2022 | 32 | 2022 |
Surgery for Deformities of the Thoracic Wall: No more than strengthening the patient's self-esteem? C Fortmann, C Petersen European Journal of Pediatric Surgery 28 (04), 355-360, 2018 | 30 | 2018 |
The utility of specific IgE testing to chlorhexidine in the investigation of perioperative adverse reactions J Anderson, M Rose, S Green, SL Fernando Annals of Allergy, Asthma & Immunology 114 (5), 425-426. e1, 2015 | 29 | 2015 |
Bisphenol A may reduce the efficacy of androgen deprivation therapy in prostate cancer JK Hess-Wilson Cancer Causes & Control 20, 1029-1037, 2009 | 28 | 2009 |
Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult JK Hess-Wilson, HK Daly, WA Zagorski, CP Montville, KE Knudsen Cancer research 66 (24), 11998-12008, 2006 | 26 | 2006 |